Neurotensin in vitro markedly reduces the affinity in subcortical limbic 3H-N-propylnorapomorphine binding sites.
D000818:Animals; D001058:Apomorphine / Q000031:analogs & derivatives* / Q000378:metabolism; D008032:Limbic System / Q000378:metabolism*; D008297:Male; D009496:Neurotensin / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D011956:Receptors, Cell Surface / Q000378:metabolism*; D011954:Receptors, Dopamine / Q000378:metabolism*; D017448:Receptors, Dopamine D2; D018028:Receptors, Neurotensin; D011957:Receptors, Opioid / Q000378:metabolism*
D011956:Receptors, Cell Surface; D011954:Receptors, Dopamine; D017448:Receptors, Dopamine D2; D018028:Receptors, Neurotensin; D011957:Receptors, Opioid; D009496:Neurotensin; C009074:N-n-propylnorapomorphine; D001058:Apomorphine